Artivion, Inc. (AORT)
19.10
-0.30
(-1.55%)
USD |
NYSE |
Nov 13, 16:00
19.10
0.00 (0.00%)
Pre-Market: 19:59
Artivion Total Assets (Quarterly) : 1.042B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.042B |
| June 30, 2026 | 1.072B |
| March 31, 2026 | 883.16M |
| December 31, 2025 | 884.80M |
| September 30, 2025 | 857.66M |
| June 30, 2025 | 838.39M |
| March 31, 2025 | 791.16M |
| December 31, 2024 | 789.10M |
| September 30, 2024 | 803.14M |
| June 30, 2024 | 789.54M |
| March 31, 2024 | 784.01M |
| December 31, 2023 | 792.40M |
| September 30, 2023 | 774.79M |
| June 30, 2023 | 777.86M |
| March 31, 2023 | 757.07M |
| December 31, 2022 | 762.80M |
| September 30, 2022 | 742.73M |
| June 30, 2022 | 764.86M |
| March 31, 2022 | 781.86M |
| December 31, 2021 | 793.05M |
| September 30, 2021 | 818.65M |
| June 30, 2021 | 810.50M |
| March 31, 2021 | 794.83M |
| December 31, 2020 | 789.40M |
| September 30, 2020 | 782.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 693.25M |
| March 31, 2020 | 621.03M |
| December 31, 2019 | 605.65M |
| September 30, 2019 | 592.60M |
| June 30, 2019 | 597.12M |
| March 31, 2019 | 586.93M |
| December 31, 2018 | 571.09M |
| September 30, 2018 | 569.70M |
| June 30, 2018 | 570.45M |
| March 31, 2018 | 583.18M |
| December 31, 2017 | 589.69M |
| September 30, 2017 | 326.14M |
| June 30, 2017 | 322.22M |
| March 31, 2017 | 319.37M |
| December 31, 2016 | 316.14M |
| September 30, 2016 | 308.86M |
| June 30, 2016 | 303.04M |
| March 31, 2016 | 297.16M |
| December 31, 2015 | 181.18M |
| September 30, 2015 | 179.98M |
| June 30, 2015 | 176.07M |
| March 31, 2015 | 173.20M |
| December 31, 2014 | 176.16M |
| September 30, 2014 | 175.16M |
| June 30, 2014 | 173.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 108.25B |
| AngioDynamics, Inc. | 241.93M |
| Alphatec Holdings, Inc. | 796.74M |
| AtriCure, Inc. | 717.54M |
| Baxter International, Inc. | 19.41B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 595.69M |
| Shareholders Equity (Quarterly) | 446.40M |
| Debt to Equity Ratio | 0.9118 |
| Current Ratio | 3.719 |
| Net Debt Paydown Yield | -2.57% |